Hot

Diagnostic Devices: Global Market Trends, Technologies, and Buying Guide for 2026

Posted on by admin5

Diagnostic devices are reshaping how healthcare providers detect, monitor, and manage disease, from high-end imaging systems in hospitals to compact point-of-care testing instruments used in clinics and at home. As demand for fast, accurate diagnosis grows worldwide, understanding this landscape is now critical for clinicians, investors, and medical technology buyers.

What Are Diagnostic Devices and Why They Matter

Diagnostic devices are medical tools and systems designed to detect, measure, and analyze health conditions so clinicians can make informed decisions about patient care. They range from basic stethoscopes and thermometers to advanced MRI scanners, CT systems, molecular diagnostics, and AI-enabled imaging platforms. In 2026, diagnostic equipment sits at the center of preventive care, chronic disease management, and value-based healthcare models.

These devices support early detection of cardiovascular disease, diabetes, cancer, respiratory conditions, neurological disorders, and infectious diseases. They are also essential in emergency medicine, perioperative care, and population screening programs. As more countries focus on lowering hospitalizations and improving outcomes, investments in accurate and timely diagnostics are becoming a strategic priority for health systems.

Global Market Trends for Diagnostic Devices

The medical devices sector, including diagnostic devices, is forecast to maintain a strong growth trajectory with a compound annual growth rate close to 7 percent between 2026 and 2031, driven by an aging population, chronic disease prevalence, and expanding access to care in emerging markets. Within this ecosystem, diagnostic devices are one of the fastest-growing product classes, particularly in imaging, in vitro diagnostics, and point-of-care testing.

Diagnostic centers and outpatient testing facilities are expected to be among the most rapidly expanding end users due to the push for early detection and decentralized care. Hospitals and large clinics remain the largest buyers of imaging equipment such as X-ray, CT, MRI, ultrasound, and nuclear medicine systems, while primary care centers and urgent care clinics drive demand for compact diagnostic instruments. North America and Europe currently lead adoption, but Asia-Pacific and Latin America are accelerating as governments modernize infrastructure and private providers invest in new technology.

Point-of-care diagnostics represent a key subsegment, with global market value already in the tens of billions of dollars and projected to approach or exceed the 60 billion range by the mid-2030s. Rapid tests for glucose, cardiac markers, respiratory infections, and sexually transmitted infections are expanding beyond hospitals into pharmacies, retail clinics, and home settings. At the same time, connectivity, cloud integration, and telehealth workflows are turning diagnostic tools into intelligent, data-driven platforms.

Core Categories of Diagnostic Devices

Diagnostic devices are typically divided into several core categories, each serving specific clinical needs and settings. Understanding these segments helps buyers align purchases with their clinical and business goals.

Imaging Diagnostic Devices

Imaging diagnostic devices provide visual or functional information about internal structures and organs. Major modalities include:

  • X-ray systems for bone fractures, chest imaging, and basic musculoskeletal assessments in emergency departments, orthopedics, and primary care.

  • Computed tomography (CT) scanners offering cross-sectional imaging for trauma, oncology staging, cardiovascular analysis, and complex internal pathologies.

  • Magnetic resonance imaging (MRI) systems for soft-tissue visualization in neurology, orthopedics, oncology, and cardiovascular imaging, including high-field and open MRI configurations.

  • Ultrasound devices, including cart-based units and portable handheld systems used in obstetrics, cardiology, emergency medicine, and point-of-care imaging.

  • Nuclear imaging systems such as PET and SPECT scanners used for functional imaging, oncology, cardiology, and neurology.

Imaging equipment often requires significant capital investment, specialized infrastructure, and trained radiology staff but delivers high clinical value and strong reimbursement in many markets.

In Vitro Diagnostic Devices

In vitro diagnostic devices analyze biological samples such as blood, urine, saliva, and tissue to identify biomarkers, pathogens, and chemical parameters. Key segments include:

  • Clinical chemistry analyzers for electrolytes, liver enzymes, kidney function, lipids, and metabolic panels.

  • Immunoassay analyzers for hormones, infectious diseases, cardiac markers, oncology markers, and therapeutic drug monitoring.

  • Hematology analyzers for complete blood counts, differential analysis, and anemia assessment.

  • Coagulation analyzers for monitoring clotting disorders and anticoagulation therapy.

  • Molecular diagnostic platforms for PCR, isothermal amplification, and sequencing-based tests that detect viral, bacterial, and genetic targets.

  • Point-of-care analyzers for blood gases, lactate, electrolytes, and routine chemistry in intensive care, operating rooms, and emergency departments.

These systems range from high-throughput laboratory analyzers to compact benchtop and cartridge-based point-of-care platforms.

Routine Clinical Diagnostic Devices

Routine diagnostic devices are used in daily clinical practice and primary care, often as first-line tools in assessment and monitoring. Common examples include:

  • Stethoscopes for auscultation of heart, lung, and bowel sounds across virtually all clinical settings.

  • Sphygmomanometers and blood pressure monitors, manual and automated, for hypertension screening and cardiovascular risk management.

  • Thermometers, including infrared, tympanic, and digital models for fever assessment in clinical and home settings.

  • Pulse oximeters for monitoring oxygen saturation and pulse rate in anesthesia, critical care, respiratory medicine, and home care.

  • Ophthalmoscopes and otoscopes for eye and ear examinations in primary care and specialty clinics.

  • Spirometers and peak flow meters for lung function testing and asthma or COPD management.

Although individually less expensive, these high-volume devices are critical for frontline diagnostics, telemedicine kits, and home-care monitoring.

Also check:  How Can the Medical Equipment Resale Market Drive Efficiency and Profitability in 2026?

Point-of-Care and Home Diagnostic Devices

Point-of-care diagnostic devices bring testing closer to the patient, reducing turnaround time and enabling faster decisions. Major applications include:

  • Blood glucose meters and continuous glucose monitors for diabetes self-management and remote monitoring.

  • Rapid antigen and molecular tests for respiratory infections, including influenza and other viral pathogens.

  • Cardiovascular point-of-care tests such as troponin and D-dimer used in emergency and urgent care to triage chest pain and suspected thromboembolism.

  • Pregnancy and fertility tests used in clinics and at home.

  • Multi-parameter point-of-care analyzers for ICU, operating rooms, and emergency departments.

An emerging category includes wearable diagnostic sensors and at-home self-testing kits integrated with mobile apps and telehealth platforms, supporting chronic disease management and virtual care models.

Top Diagnostic Devices and Use Cases

The following table highlights widely used diagnostic device types, their key advantages, typical ratings or perceived value, and common use cases across healthcare settings.

Diagnostic Device Type Key Advantages Ratings / Perceived Value Primary Use Cases
Stethoscopes Low cost, universal use, immediate assessment, no power required Very high utility in primary and acute care Routine physical exams, cardiovascular and respiratory assessment
Digital blood pressure monitors Automated, accurate, easy to use in clinic and home High patient adoption and clinician trust Hypertension screening, chronic cardiovascular management
Pulse oximeters Non-invasive, real-time oxygen and pulse data Essential in critical and respiratory care Anesthesia, ICU, emergency rooms, home oxygen therapy
Clinical chemistry analyzer High throughput, broad test menu Core asset in diagnostic labs Metabolic panels, liver and kidney function, lipid profiles
Immunoassay analyzer Sensitive and specific biomarker detection High diagnostic value for multiple specialties Cardiac markers, hormones, infectious diseases, oncology markers
Hematology analyzer Fast complete blood count and differential Standard in hospital and reference labs Infection, anemia, oncology, pre-surgical assessments
PCR-based molecular system High sensitivity and specificity for pathogens and genes Critical in infectious disease and genetics Viral and bacterial detection, resistance markers, genetic testing
X-ray system Widely available, versatile, relatively low imaging cost Foundational imaging modality Trauma, chest imaging, orthopedic evaluations
CT scanner Rapid cross-sectional imaging, broad diagnostic scope High-value modality for acute and complex cases Stroke, trauma, oncology staging, vascular imaging
MRI system Superior soft-tissue contrast, non-ionizing Flagship diagnostic technology in advanced centers Neurology, musculoskeletal, oncology, cardiology
Ultrasound device Portable options, no ionizing radiation, real time Very high adoption in many specialties Obstetrics, cardiology, emergency imaging, guided procedures
Point-of-care blood gas analyzer Immediate critical care data Essential in acute and perioperative care ICU ventilation management, operative monitoring, emergency medicine
Glucose meter and CGM Patient-operated, continuous monitoring options High patient impact, payer support Diabetes diagnosis, titration of therapy, remote monitoring
Rapid antigen and molecular tests Fast results, simple workflows Strong during outbreaks and routine screening Respiratory infections, sexually transmitted infections, travel and workplace testing

Competitor Comparison Matrix: Key Diagnostic Device Segments

When evaluating diagnostic devices, buyers compare not only brands but also entire categories based on cost, workflow, clinical value, and implementation complexity. The matrix below outlines how major diagnostic categories differ on practical purchasing criteria.

Category Typical Cost Level Implementation Complexity Data Connectivity Primary Setting Time to Result
Routine clinic devices (stethoscopes, BP monitors, thermometers, oximeters) Low Very low Limited to basic or Bluetooth models Primary care, home, telehealth kits Immediate
Point-of-care analyzers (blood gases, rapid tests, handheld analyzers) Low to medium Low to medium Increasingly cloud or EHR connected Emergency, ICU, clinics, retail health Minutes
Core lab analyzers (chemistry, immunoassay, hematology, coagulation) Medium to high High, requires lab infrastructure Fully integrated with LIS and EHR Hospital labs, reference labs Under an hour for routine tests
Molecular diagnostics (PCR, isothermal, syndromic panels) Medium to very high Medium to high depending on platform Strong connectivity and data management Labs, high-end clinics, some POC units From minutes to a few hours
X-ray systems Medium Medium, requires shielding and radiology workflows Often integrated with PACS and EHR Hospitals, imaging centers, clinics Minutes
CT scanners High High, with significant infrastructure needs Full PACS and EHR integration Hospitals, advanced imaging centers Minutes
MRI systems Very high Very high, including shielding and staffing Full PACS and EHR integration Large hospitals, specialty centers Tens of minutes to an hour
Ultrasound systems Medium Medium, training dependent Often DICOM and PACS compatible Hospitals, clinics, point of care Real time
Nuclear imaging (PET/SPECT) Very high Very high, radiopharmaceutical supply required Complex integration with imaging IT Tertiary centers, oncology facilities Tens of minutes to hours

This matrix supports health system leaders, biomedical engineers, and procurement teams in prioritizing investments according to budget, clinical need, and digital strategy.

Core Technologies Powering Modern Diagnostic Devices

Modern diagnostic devices rely on a combination of hardware innovation, advanced software, and connected infrastructure. Several technology pillars stand out in 2026.

Imaging Technologies and AI

X-ray, CT, MRI, ultrasound, and nuclear imaging have all advanced in resolution, speed, and radiation safety. Low-dose CT, high-field MRI, and advanced ultrasound probes enable clearer images and faster exams. Artificial intelligence and machine learning are increasingly embedded in imaging workflows, providing automated detection of anomalies, triage of urgent cases, and quantitative analysis for oncology, neurology, and cardiology.

Also check:  Clinical Disposable Accessories: Comprehensive Guide to Safer, Smarter Hospital Workflows

AI-based reconstruction and image enhancement improve quality even at lower doses, while decision-support algorithms suggest differential diagnoses and highlight high-risk findings. Cloud-based image sharing supports remote reporting and tele-radiology, addressing workforce shortages and enabling 24/7 coverage, especially in underserved regions.

Molecular Diagnostics and CRISPR-Based Testing

Molecular diagnostic devices have moved from specialized reference labs into mainstream hospitals and, in some cases, closer to point-of-care. Real-time PCR systems provide rapid detection of viral and bacterial pathogens, while syndromic panels allow simultaneous testing of multiple targets from a single sample. Emerging CRISPR-based diagnostic platforms offer high specificity and rapid workflows with minimal instrumentation, making them attractive for decentralized settings.

These technologies are crucial for infection control, antimicrobial stewardship, and precision oncology. Companion diagnostics tied to targeted therapies depend on high-quality molecular testing for actionable genetic and biomarker information.

Point-of-Care Platforms and Miniaturization

Miniaturization and microfluidics enable compact analyzers that perform complex tests at the bedside or in outpatient settings. Disposable cartridges, integrated reagents, and embedded quality controls simplify operation and reduce manual steps. Many systems are designed for non-laboratory staff, such as nurses and paramedics, with intuitive interfaces and automated result interpretation.

Battery-powered and portable devices are increasingly used in ambulances, field hospitals, rural clinics, and home-care programs. Combined with automated data transfer to electronic health records, these platforms shorten decision cycles and improve care in time-sensitive conditions such as sepsis, myocardial infarction, and stroke.

Connectivity, IoT, and Data Integration

Connected diagnostic devices transmit data securely to electronic health records, laboratory information systems, and cloud platforms for analytics and population health management. Wi-Fi, cellular connectivity, and IoT devices enable near real-time remote monitoring and telehealth services. Wearable diagnostic devices and home testing kits feed continuous streams of physiologic data, enabling proactive interventions and risk stratification.

Cybersecurity, interoperability standards, and regulatory expectations around software as a medical device are shaping product development. Vendors that provide robust integration, API access, and compliance with data protection frameworks are gaining competitive advantages with health systems that prioritize digital transformation.

Real User Cases and ROI from Diagnostic Devices

The value of diagnostic devices is best understood through real-world user cases that quantify clinical and financial outcomes. Across hospitals, clinics, and diagnostic centers, several patterns emerge.

In emergency departments, adding point-of-care troponin and D-dimer testing reduces time to rule out myocardial infarction or pulmonary embolism by tens of minutes compared with central lab workflows. This translates into shorter length of stay for low-risk patients, improved door-to-disposition times, and higher throughput during peak demand periods. Hospitals often report faster bed turnover and better patient satisfaction scores.

Intensive care units that implement bedside blood gas and lactate analyzers see more rapid titration of ventilation and hemodynamic support protocols. Early detection of deteriorating patients reduces complications, decreases ICU length of stay, and supports bundled payment and value-based care targets. For sepsis bundles, timely lactate measurements are directly linked to performance metrics and reimbursement incentives.

Primary care networks that deploy standardized digital blood pressure monitors, spirometers, and point-of-care HbA1c devices can identify high-risk patients earlier and adjust therapies during a single visit. This reduces follow-up appointments, unnecessary referrals, and emergency visits. In chronic disease management programs for hypertension, diabetes, and COPD, such diagnostic tools are central to achieving quality metrics tied to payer contracts.

Diagnostic imaging investments produce strong returns when coupled with optimized scheduling, protocol standardization, and teleradiology coverage. For example, stroke centers that add advanced CT and MRI capabilities with perfusion imaging can support endovascular therapy programs, capturing higher acuity referrals and improving patient outcomes. Improved diagnostic accuracy reduces repeat imaging and associated costs.

In outpatient laboratories and diagnostic centers, automation of chemistry, hematology, and immunoassay processing reduces labor costs and minimizes errors. Result turnaround times are shortened, allowing providers to see more patients with same-day results. Diagnostic centers often leverage extended hours and online access to reports to attract both referring physicians and self-pay patients.

Company Background: ALLWILL’s Role in Diagnostic Devices

Amid this evolving landscape, ALLWILL is redefining B2B medical aesthetics and diagnostic device sourcing by focusing on innovation, trust, and efficiency. Rather than simply supplying equipment, the company concentrates on solving the lifecycle challenges practitioners face when sourcing, maintaining, and upgrading diagnostic and energy-based devices, supported by its Smart Center for inspection, repair, and refurbishment and by vendor management and inventory platforms that streamline access to vetted technicians, trainers, and suitable equipment across budgets.

Buying Guide: How to Select Diagnostic Devices for Your Practice

Choosing diagnostic devices requires balancing clinical needs, financial constraints, and long-term strategy. A structured approach helps clinical leaders and procurement teams make better decisions.

First, define the clinical scope and patient population. A tertiary hospital with a stroke unit, oncology services, and interventional cardiology will prioritize advanced CT, MRI, ultrasound, and molecular platforms, while a primary care clinic needs reliable stethoscopes, blood pressure monitors, thermometers, spirometers, ECG devices, and basic point-of-care tests. Consider disease burden, referral patterns, and service lines you plan to grow.

Also check:  Is the 2016 ZELTIQ Aesthetics CoolSculpting System Still a Smart Investment for Modern Medical Aesthetic Clinics?

Second, assess workload and throughput requirements. High-volume labs should invest in automated analyzers with robust sample handling and middleware, while smaller facilities may prefer modular systems that scale over time. Imaging centers must model expected daily studies to size X-ray, CT, and ultrasound capacity, accounting for peak times and potential expansion.

Third, evaluate interoperability and digital strategy. Devices that integrate seamlessly with existing electronic health records, PACS, and laboratory information systems reduce manual data entry, minimize errors, and support advanced analytics. Ensure that diagnostic devices support standard communication protocols, secure data transfer, and software updates to meet regulatory and cybersecurity expectations.

Fourth, examine total cost of ownership. Purchase price is only one component. Ongoing service contracts, consumables, reagents, software licenses, training, and downtime risks all affect return on investment. Compare different financing options, including leasing, subscription models, and trade-in or trade-up programs that allow technology refresh without unpredictable capital spikes.

Fifth, consider usability and training. Devices with intuitive interfaces, clear workflows, and built-in quality controls reduce training time and error rates. For point-of-care diagnostics and decentralized testing, ease of use by nonlab staff is a major success factor. Simulation, online training modules, and vendor-supported onboarding programs can accelerate adoption.

Finally, validate device performance, regulatory compliance, and vendor support. Look for evidence from clinical studies, peer-reviewed evaluations, and post-market performance data. Ensure that devices meet regulatory requirements in your region and that the supplier offers reliable technical support, spare parts availability, and transparent service levels.

Regulatory, Quality, and Safety Considerations

Diagnostic devices operate in a highly regulated environment. Compliance with regional regulations and international standards is essential for patient safety and legal operation. Manufacturers must demonstrate safety, performance, and risk management, while healthcare providers must ensure proper installation, use, and maintenance.

Quality management systems, preventive maintenance programs, and regular calibration are mandatory for accurate results. Imaging equipment requires radiation safety programs, shielding calculations, and dose monitoring to protect patients and staff. Laboratory devices must comply with quality control policies, proficiency testing, and accreditation standards such as ISO-based frameworks.

Cybersecurity is increasingly important as diagnostic devices become connected. Protection against unauthorized access, data breaches, and ransomware requires secure configuration, patch management, user authentication, and network segmentation. Providers should align device-level security with enterprise information security policies and conduct periodic assessments.

Future Trends Shaping Diagnostic Devices

Diagnostic devices are entering a new phase where data, automation, and personalization drive innovation. Several trends are particularly influential.

First, decentralized and home-based diagnostics will expand. Patients will conduct more tests at home using connected devices and self-collection kits, feeding data directly into virtual care platforms. Chronic disease programs and remote patient monitoring will rely on wearable sensors, smartphone-integrated diagnostics, and algorithm-driven alerts.

Second, AI and advanced analytics will permeate nearly all diagnostic modalities. Beyond image interpretation, algorithms will integrate lab results, imaging findings, and physiologic data to support risk prediction and treatment selection. Real-time decision support at the point of care will help clinicians manage rising caseloads and complexity.

Third, combinational platforms that merge imaging, lab data, and genomics will accelerate precision medicine. Multi-omics diagnostics will guide targeted therapies and personalized prevention strategies, especially in oncology, cardiology, and rare diseases. Molecular and companion diagnostic devices will continue to grow alongside novel therapies.

Fourth, sustainability and energy efficiency will become more important in purchasing decisions. Hospitals and labs will consider environmental impact, energy consumption, and waste reduction when selecting large imaging systems and high-throughput analyzers. Vendors that offer refurbishment, modular upgrades, and longer device lifecycles will be favored.

Fifth, emerging markets will play a larger role in driving innovation. Low-cost, rugged diagnostic devices designed for limited-resource settings will increasingly influence global portfolios. Portable ultrasound, battery-operated point-of-care analyzers, and simplified molecular tests will support universal health coverage initiatives.

Three-Level Conversion Funnel CTA for Diagnostic Device Buyers

If you are exploring diagnostic devices for the first time, start by mapping your clinical priorities, patient population, and current diagnostic gaps, then list the tests and imaging capabilities required to close those gaps. This simple diagnostic roadmap will guide which technologies you should evaluate and in what order.

If you already use diagnostic devices but want to improve performance, review your current fleet, utilization rates, downtime, and integration issues, and identify where point-of-care testing, connectivity upgrades, or workflow redesign could shorten turnaround times or reduce costs. Use real data from your lab and imaging systems to quantify bottlenecks and target improvements.

If you are ready to invest in new diagnostic devices or upgrade existing systems, engage clinical leaders, biomedical engineers, and finance stakeholders in a structured evaluation that compares total cost of ownership, interoperability, service models, and clinical impact. By aligning technology choices with strategic goals, you can turn diagnostic devices into a powerful engine for better outcomes, stronger patient satisfaction, and sustainable growth in an increasingly demanding healthcare environment.

admin5

联系我们|Contact Form

TERMS AND CONDITIONS 

These Terms and Conditions (these “Terms”), together with the attached or accompanying quote page (the “Quote,” collectively, this “Agreement”), exclusively govern the sale by Healthcare Markets, Inc., a Delaware corporation doing business as “Powered by MRP” (“MRP”), and the purchase and use by the buyer set forth on the Quote (“Buyer”), of the equipment (the“Equipment”) and/or services (the “Services”).

        1.  EQUIPMENT AVAILABILITY. Equipment offered for sale by MRP is subject to availability. MRP shall not be liable to Buyer in case of stock outage or unavailability of the Equipment. MRP reserves the right to change the equipment offered for sale at any time and without notice to Buyer. Availability of equipment may be determined when an order is placed, and, if unavailable, MRP will inform Buyer of such unavailability, offer other available equipment as substitution or cancel the order. Such cancelled order will be refunded by MRP to Buyer, except for an order for a Special Order Product, which cannot be cancelled once the order is placed.

        2.  PRICES. Written price quotations on the Quote shall last for ten (10) days from the date issued and then automatically expire, and quoted prices do not include taxes, freight, handling, duty, insurance or other similar charges, which Buyer must pay unless waived in writing by MRP or a valid tax exemption certificate is provided to MRP. Notwithstanding the foregoing, all published prices may be changed by MRP at any time without notice to Buyer.

        3.  TERMS OF PAYMENT. Unless otherwise agreed to on the Quote or in writing by MRP, prepayment in full is required, by bank transfer, cash, credit card or certified check, and where partial pre-payment is permitted, such payment shall be nonrefundable with the balance due net thirty (30) days from the date of invoice. MRP reserves the right to modify or revoke any credit previously extended. Past due balances shall be subject to a service charge of one and one-half percent (1.5%) per month, not to exceed the maximum amount permitted by applicable law. Buyer agrees to pay all fees, charges or other sums payable hereunder, including collection fees incurred, with no right of set-off or reduction of any nature unless approved in writing by an MRP corporate officer (an “MRP Officer”). Buyer hereby grants, and MRP reserves, a purchase money security interest in the Equipment purchased, and in any proceeds thereof, to secure Buyer’s payment obligations hereunder. Buyer shall cooperate fully with MRP to execute such documents and accomplish such filings and/or recordings as MRP may deem necessary for the protection of its interests in the Equipment furnished to Buyer, and in the event Buyer does not aid within a reasonable time after MRP asks Buyer to do so, Buyer hereby authorizes and appoints MRP as Buyer’s attorney-in-fact to execute, deliver and file at any time, any financing statement and/or take any other action permitted by applicable law to perfect, enforce, continue and amend MRP’s security interest in any jurisdiction deemed appropriate by MRP. Buyer agrees that upon nonpayment of any charges due to MRP, MRP may cancel or delay delivery of the Equipment and/or suspend any applicable service coverage, which may resume only when MRP receives payment in full, and the warranty period will continue to run during such time of nonpayment although warranty service will not be available.

        4.  SHIPMENT AND DELIVERY. Delivery dates are estimated, and partial deliveries are allowed. MRP shall not be liable for or in respect of any loss or damage arising from any delay in filling any order, failure to deliver or delay in delivery. No delay in the shipment or delivery of any Equipment relieves Buyer of its obligations under this Agreement, including, without limitation, accepting delivery of any remaining installment(s) of the Equipment, if applicable. Buyer must pay for, and hold MRP harmless from, all shipping, delivery, and insurance expenses unless otherwise agreed in writing by an MRP Officer or otherwise indicated on the Quote. MRP will not assume any liability if MRP selects the shipping methods nor will any carrier be deemed to be MRP’s agent. “Time is of the essence” terms will not apply to orders accepted by MRP. Title and risk of loss of the Equipment shall pass to Buyer, and delivery shall be deemed completed, when the Equipment is delivered to Buyer’s address. Should loss or damage in transit occur, Buyer’s payment obligations will not be affected. Buyer is liable for all costs for MRP’s holding or storing of the Equipment if delivery is delayed by Buyer or at Buyer’s request. If delivery is delayed over thirty (30) days, MRP may, at its option and upon notice to Buyer, cancel that and all future deliveries without further liability or obligation of any kind.

        5.  FORCE MAJEURE. MRP shall not be responsible for delays or failure to render or service any Equipment and/or perform any Service due to any cause beyond MRP’s control, including, but not limited to: (a) acts of God; (b) flood, fire, earthquake, epidemic, pandemic or explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or act, riot or other civil unrest; (d) government order, law or actions; (e) embargoes or blockades in effect on or after the date of this Agreement; (f) national or regional emergency; (g) strikes, labor stoppages or slowdowns or other industrial disturbances; and (h) telecommunication breakdowns, power outages or shortages, lack of warehouse or storage space, inadequate transportation services or inability or delay in obtaining supplies of adequate or suitable material (each, a “Force Majeure Event”). Any delivery date may be extended, at MRP’s sole discretion, to the extent of any delay resulting from any Force Majeure Event.

        6.  ACCEPTANCE; INSPECTION. Except for Special Order Products, Buyer shall inspect all Equipment upon delivery and within forty-eight (48) hours of delivery to Buyer shall give written notice to MRP of any error or claim that any Equipment does not conform to the terms of this Agreement; any claims not made within such period shall be deemed waived and released, with the Equipment being accepted by Buyer. Except as provided under this Section 6 and Section 7 hereof, all sales of Equipment to Buyer are made on a one-way basis, and Buyer has no right to return Equipment purchased under this Agreement to MRP. Subject to the warranty set forth in Section 8(c)(iv), Services are deemed to be accepted by Buyer upon completion of their performance by MRP.

        7.  CANCELLATION CHARGES AND RETURNED EQUIPMENT POLICY. Returns and cancellations are not permitted without written approval by an MRP Officer, which shall be made in such MRP Officer’s sole discretion. If approved, MRP will issue a return merchandise authorization number, which Buyer must include in the returned packaging, and Buyer must pay MRP either a (a) twenty percent (20%) restocking charge on the purchase price of the item if Buyer’s written request for return or cancellation is received by MRP’s headquarters after MRP’s original shipment of the Equipment or (b) a ten percent (10%) cancellation damages charge if Buyer’s request was received before said shipment. The foregoing charges are agreed upon, not as a penalty, but because of the difficulty of computing actual damages, and until the applicable charge is paid and the Equipment has been received back by MRP in new condition, no refund will be given. This document or copies hereof may be filed with the appropriate authorities as a financing statement to pursue such charges. In no case will shipping and freight costs be refunded. Removed, replaced or substituted equipment and parts (collectively, “Returned Equipment”) shall become MRP’s property, with title and ownership transferring to MRP upon the earlier of its return or replacement, with MRP owing no other obligations on the Returned Equipment. Buyer hereby agrees to indemnify, defend and hold harmless MRP Indemnitees from any claims, costs, losses, attorneys’ fees and expenses related to any third-party attempts to claim ownership of the Returned Equipment or dispute any trade-in, removal, substitution or replacement, and the remaining provisions shall continue in full force and effect.

        8.  MRP’S WARRANTIES, IF ANY.

(a) Equipment Sold “As Is.” UNLESS OTHERWISE STATED ON THE QUOTE OR IN A WRITING SIGNED BY AN MRP OFFICER, BUYER AGREES THAT THE EQUIPMENT SOLD IN THIS AGREEMENT IS BEING SOLD ON AN “AS IS,” “AS AVAILABLE” BASIS, SUBJECT TO SECTIONS 8(c) AND 9, AND HAVE NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, WHETHER IMPLIED OR ARISING BY LAW, STATUTE OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, WORKMANLIKE MANNER, QUALITY, ACCURACY, TITLE, AND/OR IMPLIED FROM A COURSE OF DEALING OR PERFORMANCE USAGE IN TRADE.

(b) Special Order Product. If this Agreement includes the sale of a product that MRP does not currently have or typically keep in stock, in MRP’s sole determination, but is acquired from a third party specifically for Buyer (a “Special Order Product”), then Buyer agrees that (i) Buyer, at its sole discretion, has made the selection of such Special Order Product, (ii) such Special Order Product is being acquired by MRP solely at the request of Buyer, (iii) no representation, warranty or guarantee has been made by MRP with respect to such Special Order Product, (iv) the obligation of Buyer to pay MRP for the Special Order Product is absolute and unconditional, and (v) Buyer waives and releases MRP from all claims, damages and losses arising out of such Special Order Product. Special Order Products carry no right to inspection before or after delivery, and MRP is not responsible for examining or evaluating such Special Order Products. MRP makes no warranty about Special Order Products and offerings of the third party (including description of the Special Order Product). MRP does not assume any responsibility or liability for the actions, product and content of all these and any other third parties. If there are any problems with any Special Order Product, Buyer must contact the manufacturer of such Special Order Product for assistance.

(c) Limited Warranties, If Any.

(i) If the Quote expressly states that the Equipment has a warranty for a certain time (a “Warranty Period”), then MRP warrants that the Equipment shall be in good working order under normal use for the Warranty Period, which Warranty Period shall commence from the date of delivery to Buyer (the “Delivery Date”), unless otherwise approved by an MRP Officer in writing, except for the following: (A) New (not used or pre-owned) Equipment that is to be serviced by MRP: if the Quote is silent, warranted to be in good working order under normal use for one hundred eighty (180) days from the Delivery Date; (B) Used Equipment sold refurbished by MRP: if the Quote is silent, warranted to be in good working order under normal use for thirty (30) days from the Delivery Date; (C) Consumable/disposable Equipment: if the Quote is silent, warranted to have been shipped from MRP in functional condition, and no additional warranty shall apply; no service shall be provided either. These items should be inspected for obvious damage, subject to Section 6 and 8(e), and MRP’s obligation under this warranty and this Section 8(c)(i)(C) is limited to replacement of the Equipment; and (D) New (not used or pre-owned) Equipment that is to be serviced by the manufacturer: if the Quote is silent, MRP makes no warranty for any such Equipment. Buyer’s sole warranty for any such Equipment, if any, shall be the original manufacturer’s warranty, which MRP agrees to pass on to Buyer, as applicable. (ii) For the limited warranties of Section 8(c)(i), including exceptions (A) and (B), but not (C) or this (D), Buyer is entitled to telephone, e-mail and video technical assistance and, subject to Sections 8(d) and 8(e), repair or replacement of such Equipment, in MRP’s sole discretion, should the Equipment become inoperative through normal use during the Warranty Period. Loaner equipment is not provided, but if so arranged by MRP, Buyer shall pay MRP the cash list price of any unreturned loaner equipment provided by MRP within seven (7) days of a written demand from MRP. (iii) Repair or replacement under any limited warranty of Equipment may be with parts or products that are new, used or refurbished, carrying the same limited warranty for the remaining term of the original item. Repairs or replacements shall not interrupt, extend or prolong the term of the warranty. (iv) For Services purchased under this Agreement, MRP warrants that the Services shall be performed using competent personnel in a professional manner in accordance with generally recognized industry standards for similar services. Subject to Sections 6 and 8(e) herein, if any Service was not performed in accordance with the aforementioned warranty, then MRP shall, in its sole discretion, either (A) repair or re-perform the applicable Service, or (B) credit or refund the price of such Service at the pro rata contract rate.

(d) Exclusions. MRP reserves the right, without liability, to void all warranties and remedies, including any obligation to service, repair, replace or otherwise remedy defects, errors or failures of the Equipment due to the occurrence of any of these events, and MRP shall be in no way responsible for: (i) handling, maintenance or use in a manner that is inconsistent with and/or contrary to the original manufacturer’s or MRP’s recommended procedures and/or instructions, including, without limitation, use of or with an unauthorized third-party good or part; (ii) any failure or damage resulting from negligence, alteration, modification or relocation of the Equipment by Buyer, its employees, agents or representatives; (iii) attempted or actual unauthorized dismantling, disassembling, service, repair, addition or change of the Equipment, including, without limitation, changing the serial number or shot count; (iv) abnormal wear and tear, including, without limitation, use under abnormal conditions (e.g., unclean, dusty, or exposure to extreme electromagnetic radiation, temperature or humidity); or (v) damage or failure of the Equipment due to a Force Majeure Event or a problem in the premises of the Equipment. In any of the above situations, or for any Equipment that has no warranty, MRP has sole discretion to service the Equipment, at Buyer’s expense, at MRP’s then-in-effect rates for service, labor, travel, shipping and materials.

(e) Notice and Inspection. The limited warranties contained in this Section 8 are made on condition that immediate written notice of any noncompliance with the Equipment’s and/or the Service’s warranty be given to MRP, and provided that MRP’s inspection reveals that Buyer’s claim is valid under the terms of such warranty.

        9.  DISCLAIMERS; NO OTHER WARRANTY. EXCEPT TO THE EXTENT AS PROVIDED IN SECTION 8(c)(i)(D), BUYER ACKNOWLEDGES THAT MRP IS NOT BOUND BY ANY WARRANTY THAT MAY BE SET FORTH IN A MANUFACTURER’S WRITTEN MATERIALS THAT WOULD HAVE APPLIED HAD BUYER PURCHASED THE EQUIPMENT DIRECTLY FROM THE MANUFACTURER IN ITS UNUSED STATE. BUYER ACKNOWLEDGES THAT BUYER HAS NOT RELIED UPON ANY WARRANTY OTHER THAN AS SET FORTH IN THIS AGREEMENT. IN ADDITION, BUYER ALSO HEREBY ACKNOWLEDGES AND AGREES THAT ANY ORAL OR WRITTEN STATEMENTS CONCERNING USE AND REGULATION OF MEDICAL DEVICES SOLD BY MRP ARE AND SHALL BE CONSTRUED AS FOR INFORMATIONAL PURPOSES ONLY AND WITHOUT WARRANTY OR ASSURANCE BY MRP AS TO THEIR ACCURACY OR VALIDITY. MRP ALSO HEREBY DISCLAIMS ANY AND ALL WARRANTIES REGARDING OTHER MEDICAL CARE OR HELP, INCLUDING THE SELECTION OF AESTHETIC AND MEDICAL PROCEDURES AND PRODUCTS FOR, OR CARE OF, PATIENTS. THE LIMITED WARRANTIES OF THIS AGREEMENT, IF APPLICABLE TO ANY EQUIPMENT OR SERVICE FURNISHED UNDER THIS AGREEMENT, CONSTITUTE THE ONLY WARRANTIES MADE WITH RESPECT TO THE EQUIPMENT AND/OR SERVICE AND ANY DEFECT, DEFICIENCY OR NONCONFORMITY. TO THE EXTENT PERMITTED BY LAW, SUCH WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY EXPRESS OR IMPLIED WARRANTY OF MERCHANTABILITY, TITLE, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.

        10.  LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, UNDER NO CIRCUMSTANCES SHALL MRP BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR SPECIAL DAMAGES, ARISING FROM, RELATED TO OR CAUSED, DIRECTLY OR INDIRECTLY, WHETHER FORESEEABLE OR NOT, BY THE EQUIPMENT AND/OR THE SERVICES, THE USE OR INABILITY TO USE THE EQUIPMENT, THE RESULTS GENERATED FROM THE EQUIPMENT AND/OR THE SERVICES, THIS AGREEMENT, ANY OTHER ACT OR OMISSION OF MRP, OR BASED UPON ANY OTHER LEGAL THEORY. IN NO EVENT SHALL MRP BE LIABLE FOR ANY LOSSES OF REVENUE, USE, BUSINESS OPPORTUNITY, PROFIT, SAVINGS OR ANY OTHER DAMAGES DUE TO ANY CAUSE WHATSOEVER, EVEN IF MRP OR ITS AGENTS HAS BEEN ADVISED OF THE POSSIBILITY THEREOF. THE FOREGOING IS A SEPARATE, ESSENTIAL TERM OF THIS AGREEMENT, AND SHALL BE EFFECTIVE UPON THE FAILURE OF ANY REMEDY, EXCLUSIVE OR NOT. IN NO EVENT WILL MRP’S TOTAL LIABILITY UNDER THIS AGREEMENT EXCEED THE PURCHASE PRICE ACTUALLY PAID TO MRP BY BUYER FOR THE EQUIPMENT AND/OR THE SERVICES GIVING RISE TO THE CLAIM FOR WHICH DAMAGES ARE BEING SOUGHT. NO SUIT OR ACTION MAY BE BROUGHT BY BUYER, ITS SHAREHOLDERS, DIRECTORS, MANAGERS, EMPLOYEES OR AGENTS FOR ANY BREACH OF THIS AGREEMENT MORE THAN ONE (1) YEAR AFTER THE ACCRUAL OF SUCH CAUSE OF ACTION. IT IS AGREED THAT MRP’S LIABILITY IS SO LIMITED. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, BUYER ASSUMES ALL RISK AND LIABILITY FOR THE RESULTS OBTAINED BY THE USE OF ANY EQUIPMENT IN THE PRACTICE OF ANY PROCESS, WHETHER IN TERMS OF OPERATING COSTS, GENERAL EFFECTIVENESS, SUCCESS OR FAILURE, AND REGARDLESS OF ANY ORAL OR WRITTEN STATEMENTS MADE BY MRP, BY WAY OF TECHNICAL ADVICE OR OTHERWISE, RELATED TO THE USE OF THE EQUIPMENT.

        11.  BUYER’S REPRESENTATIONS AND WARRANTIES. Buyer represents and warrants to MRP that: (a) Buyer is duly organized, validly existing, and in good standing in the jurisdiction of Buyer’s formation; (b) Buyer is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required; (c) Buyer has the full right, power, and authority to enter into this Agreement and to perform Buyer’s obligations under this Agreement; (d) the execution of this Agreement by the person whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of Buyer; (e) when executed and delivered by each of MRP and Buyer, this Agreement will constitute the legal, valid and binding obligation of Buyer, enforceable against Buyer in accordance with its terms; (f) Buyer is in compliance with all applicable laws relating to this Agreement, the Equipment and the operation of Buyer’s business; (g) Buyer is not insolvent and is paying all of its debts as they become due; and (h) all financial information that Buyer has provided to MRP is true and accurate and fairly represents Buyer’s financial condition.

        12. PROPRIETARY RIGHTS.

(a) Ownership. No sale shall be construed as granting to Buyer any license or other right in, or to, any of MRP’s (i) patents; (ii) trademarks; (iii) internet domain names, whether or not trademarks, registered by any authorized private registrar or governmental authority, web addresses, web pages, websites and URLs; (iv) works of authorship, expressions, designs and design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, technical data, data files, and databases and other specifications and documentation; (v) trade secrets; (vi) environmental or other testing applicable to the Equipment and/or the Services; and (vii) industrial and other intellectual property rights, and all rights, interests, and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection pursuant to the laws of any jurisdiction throughout in any part of the world (collectively, the “Intellectual Property Rights”).

(b) Prohibited Acts. Buyer shall not (i) take any action that might interfere with any of MRP’s rights in or to Intellectual Property Rights, including MRP’s ownership or exercise thereof; (ii) challenge any right, title, or interest of MRP in or to the Intellectual Property Rights; (iii) make any claim or take any action adverse to MRP’s ownership of the Intellectual Property Rights; (iv) register or apply for registrations, anywhere in the world, for MRP’s trademarks or any other trademark that is similar to MRP’s trademarks or that incorporates MRP’s trademarks in whole or in confusingly similar part; (v) use any mark, anywhere that is confusingly

similar to MRP’s trademarks in whole or in confusingly similar part; (vi) engage in any action that tends to disparage, dilute the value of or reflect negatively on the Equipment and/or the Services or any of MRP’s trademarks; (vii) misappropriate any of MRP’s trademarks for use as a domain name without prior written consent from MRP; or (viii) alter, obscure or remove any of MRP’s trademarks, or trademark or copyright notices or any other proprietary rights notices placed on the

Equipment, marketing materials or other materials that MRP may provide.

        13.  CONFIDENTIAL INFORMATION. Without the prior written consent of MRP,Buyer, directly or indirectly, shall not disclose (and will direct its directors, shareholders, employees and agents not to disclose) any Confidential Information. The term “Confidential Information” means any information of or relating to MRP or the Equipment and/or the Services not generally known to the public (other than as a result of disclosure in violation of this Agreement) in spoken, printed, electronic or any other form or medium, including, but not limited to, business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, transactions, potential transactions, know-how, trade secrets, databases, manuals, records, supplier information, financial information, accounting information, legal information, marketing information, pricing information, payroll information, personnel information, and supplier lists.

        14.  NON-SOLICITATION. Buyer agrees not to solicit or hire any personnel of MRP involved with the delivery of the Services during the provision of such Services and for twelve (12) months after the completion of such Services; provided, however, that Buyer may hire individuals employed by MRP who, without other solicitation, respond to advertisements or solicitations aimed at the general public.

        15.  EQUITABLE REMEDIES. Buyer acknowledges and agrees that (a) a breach or threatened breach by Buyer of any of its obligations under Sections 13 or 14 would give rise to irreparable harm to MRP for which monetary damages would not be an adequate remedy and (b) in the event of a breach or a threatened breach by Buyer of any such obligations, MRP shall, in addition to any and all other rights and remedies that may be available to MRP at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove actual damages or that monetary damages will not afford an adequate remedy. Buyer agrees that Buyer will not oppose or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section 15.

        16.  INDEMNIFICATION. Buyer agrees to indemnify, defend and hold harmless MRP and its directors, shareholders, employees and agents (collectively, “MRP Indemnitees”) against any liability, damage, loss or expense incurred by or imposed in connection with any claims, suits, actions, demands or judgments arising out of (a) any breach or non-fulfillment of any representation, warranty or covenant set forth in this Agreement by Buyer or its directors, managers, employees or agents (collectively, “Buyer’s Agents”); (b) any negligent act or omission or willful misconduct of Buyer or Buyer’s Agents in connection with this Agreement; (c) any bodily injury, death of any person or damage to real or tangible personal property caused by Buyer or Buyer’s Agents, including the use of unauthorized parts in or service of the Equipment; (d) any failure by Buyer or Buyer’s Agents to comply with any applicable laws; (e) any fraud or other intentional acts by Buyer or Buyer’s Agents; and (f) the use or operation of the Equipment, including, without limitation, any medical and/or surgical procedures performed by Buyer, and any of Buyer’s Agents, using the Equipment unless said damages are determined by a court of competence jurisdiction to be solely by the gross negligence of MRP or solely as result of a breach by MRP of the limited warranties contained herein.

        17.  DEFAULTS; REMEDIES. Notwithstanding anything herein to the contrary, should Buyer fail to pay for the order or any other amount, in whole or in part, when due or perform its other obligations under this Agreement or as otherwise mutually agreed in writing between Buyer and MRP (each, a “Default”), then MRP may take any and all actions available under law or equity to collect said amounts with a ten (10) day prior written notice, including, but not limited to, enforcing its security interest, accelerating the payment of and declaring immediately due and payable any unpaid balance of the order, referral to outside collection agencies and/or commencement of legal action. MRP’s rights shall be cumulative, and it shall not be required to have attempted to realize upon to the Equipment before taking any other collection actions. MRP may require that Buyer assemble and return any or all of the Equipment to MRP and, in the event Buyer fails to return such Equipment peaceably, enter upon the premises where such Equipment is located, with or without legal process, and repossess such Equipment. Upon a Default, Buyer agrees to pay upon MRP’s demand: (i) all costs and expenses incurred by MRP or its assignee in connection with the enforcement of any remedies, including all expenses incurred in connection with the return, sale, release or other disposition of the Equipment, including attorneys’ fees and other costs incurred by MRP or its assignee in enforcing or defending its rights and remedies under this Agreement and any other written agreement between Buyer and MRP.

        18.  COMPLIANCE WITH LAWS. Buyer shall (a) carry out the transactions contemplated by this sale and deal with the Equipment in conformity with all applicable laws, rules and regulations of all government authorities, including, without limitation, export laws, (b) obtain all permits and licenses required in connection with the purchase, shipment, installation or use of the Equipment, and (c) be solely responsible to fully understand and comply with laws, rules and regulations. Any information provided is as a convenience only.

        19.  FURTHER ASSURANCES. Upon MRP’s reasonable request, Buyer shall, at its sole cost and expense, execute and deliver all such further documents and instruments, and take all such further acts, necessary to give full effect to this Agreement.

        20.  ASSIGNMENT; SUCCESSORS AND ASSIGNS. Buyer cannot delegate any duties nor assign any rights or claims under this Agreement without MRP’s prior written consent, and any such attempt or assignment shall be void. In the event that Buyer finances its acquisition of any Equipment with a third party, Buyer may direct MRP to transfer title of such Equipment to such third-party financing company, with all remaining terms and conditions of this Agreement remaining in full force and effect. This Agreement is binding on and inures to the benefit of the parties to this Agreement and their respective permitted successors and permitted assigns.

        21.  NO THIRD-PARTY BENEFICIARIES. Subject to Section 16, this Agreement benefits solely the parties to this Agreement and their respective permitted successors and assigns, and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

        22.  GOVERNING LAW; VENUE. The application of the UN Convention on Contracts for the International Sale of Goods is expressly excluded. The parties agree that any and all claims, demands, disagreements, controversies or disputes arising out of or relating to this Agreement and any agreement or document delivered in connection herewith (collectively, “Claims”) shall be governed by and construed in accordance with the laws of the State of Utah and adjudicated exclusively in the state and federal courts located in or nearest to Summit County, Utah, which courts shall have the sole and exclusive jurisdiction and venue for adjudication of all Claims. The parties hereby agree upon, consent and stipulate to the jurisdiction and venue of the aforementioned courts for the adjudication of all Claims, to the exclusion of all other courts, forums and venues whatsoever.

        23.  NON-DISPARAGEMENT. Buyer shall not disparage MRP or MRP’s trademarks, websites, products or services, or display any such items in a derogatory or negative manner on any website or in any public forum or press release.

        24.  NOTICES. Any notice, demand, or communication required, permitted or desired to be given hereunder shall be deemed effectively given when personally delivered, when sent by electronic means, when received by overnight courier, or when mailed by prepaid, certified or registered mail, return receipt requested, addressed to the other party at its address set forth on the Quote or to such other address that the receiving party may designate from time to time in accordance with this Section 25.

        25.  PUBLIC ANNOUNCEMENTS. Unless otherwise stated herein, neither party shall issue a press release or otherwise advertise, make a public statement or disclose to any third-party information pertaining to the relationship arising under this Agreement, the existence or terms of this Agreement, the underlying transactions between MRP and Buyer or agent for Buyer or refer to the other party in relation to this Agreement without the other party’s prior written approval.

        26.  ENTIRE AGREEMENT; ADDITIONAL OR INCONSISTENT TERMS. Subject to Section 32, this Agreement constitutes the sole and entire agreement between the parties hereto relating to the subject matter hereof, and any unincorporated representation, affirmation of fact, course of prior dealings, promise or condition in connection therewith, or usage of the trade, shall not be binding on either party. Terms and conditions set forth which differ from, conflict with or are not included in this Agreement shall not be part of any agreement between MRP and Buyer unless both parties specifically accept such terms and conditions in writing.

        27.  WAIVER. No waiver under this Agreement is effective unless it is in writing and signed by the party waiving its right. Any waiver authorized on one occasion is effective only in that instance and only for the purpose stated and does not operate as a waiver on any future occasion. None of the following constitutes a waiver or estoppel of any right, remedy, power, privilege or condition arising from this Agreement: any failure or delay in exercising any right, remedy, power or privilege or in enforcing any condition under this Agreement; or any act, omission or course of dealing between the parties.

        28.  SURVIVAL. Subject to the limitations and other provisions of this Agreement, the representations and warranties of Buyer contained herein shall survive the expiration or earlier termination of this Agreement for a period of twelve (12) months after such expiration o termination and (b) this Section 29 and Sections 10, 12, 13, 14, 15, 16, 17, 21, 22, 23, 24, 26, and 32 of this Agreement, as well as any other provision that, in order to give proper effect to its intent, should survive such expiration or termination, shall survive the expiration or earlier termination of this Agreement. All other provisions of this Agreement shall not survive the expiration or earlier termination of this Agreement.

        29.  RELATIONSHIP OF PARTIES. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise, employment or fiduciary relationship between the parties. Neither party has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other party or to bind the other party to any contract, agreement or undertaking with any third party.

        30.  HEADINGS. The headings in this Agreement are for reference only and do not affect the interpretation of this Agreement.

        31.  ORDER OF PRECEDENCE. In the event of conflict between the Quote, a written agreement by MRP, and these Terms, the order of priority shall be: (1) the written

agreement by MRP, if only if executed by an MRP Officer, (2) the Quote and (3) these Terms, and only to the extent of the direct conflict. Notwithstanding the foregoing, MRP shall not be bound by, and specifically objects to, any terms, conditions or other provisions, both written and oral, which are different from, in addition to or inconsistent with the provisions of this Agreement which are set forth in any purchase order, receipt, acceptance, confirmation, correspondence or otherwise of, or by, Buyer. Fulfillment of Buyer’s order shall not constitute acceptance of any of Buyer’s terms and conditions and does not serve to modify or amend the terms and conditions contained herein.

        32.  SEVERABILITY. If any part of this Agreement is held to be void, illegal or unenforceable, then it shall be deemed to be severed from this Agreement and the remaining provisions shall continue in full force and effect; provided, however, that if any fundamental term or provision of this Agreement is held to be void, illegal or unenforceable, the remainder of this Agreement shall be unenforceable. Upon a determination that any term or provision is void, illegal or unenforceable, the parties shall negotiate in good faith to modify this Agreement to effect the original intent of the parties as closely as possible in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.